Hims & Hers Health Dirección
Dirección controles de criterios 2/4
El CEO de Hims & Hers Health's es Andrew Dudum , nombrado en Jan 2017, tiene una permanencia de 7.25 años. compensación anual total es $10.82M, compuesta por 5.5% salario y 94.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 9.22% de las acciones de la empresa, por valor de $242.50M. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 3.1 años, respectivamente.
Información clave
Andrew Dudum
Chief Executive Officer (CEO)
US$14.4m
Compensación total
| Porcentaje del salario del CEO | 4.2% |
| Permanencia del CEO | 7.3yrs |
| Participación del CEO | 9.2% |
| Permanencia media de la dirección | 2.2yrs |
| Promedio de permanencia en la Junta Directiva | 3.2yrs |
Actualizaciones recientes de la dirección
Recent updates
Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
Mar 21Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Mar 12Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%
Feb 28
Hims & Hers: Turning The Profitability Corner And Returning 28%
Feb 25Hims & Hers Health: No Clear Moat Besides First Mover Advantage
Jan 23Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple
Jan 10Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)
Jan 07Hims & Hers Health Q3: The Cheapest Growth Stock Around
Dec 14Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Nov 30Hims & Hers: The Most Undervalued Small Cap Stock I See
Nov 08Hims & Hers: A Promising Company With Resolvable Challenges
Nov 02Hims & Hers: Specialization Is The Secret To Great Growth
Oct 25Hims & Hers Health: Can't Get Much Better
Sep 25The Market Is Wrong On Hims & Hers Health
Sep 18Hims & Hers: The Current Weakness Creates A Buying Opportunity
Aug 15Hims & Hers Health: Giving Investors Another Bite At The Apple
Aug 01Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues
Jul 21Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong
Jul 13Hims & Hers Health: Double-Edged Sword
Jul 02Hims & Hers: More Transparency Could Help The Stock
Jun 09Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business
Apr 19Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?
Mar 30Him & Hers Health Q4 2022 Earnings Preview
Feb 24Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance
Feb 09Hims & Hers: Profitability Pulled Forward
Jan 25Hims & Hers Health: Buy Into The Strong Growth Momentum
Jan 18Devon Energy And Hims & Hers Health - Raul Shah's Hot Take
Jan 05Hims & Hers Health: The Ultimate Pick For 2023
Dec 23Hims & Hers Health: The Unicorn (Former) SPAC For 2023
Dec 17Hims & Hers Health Seems Like A Great Pick For 2023
Dec 10Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$14m | US$612k | -US$24m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$47m |
| Mar 31 2023 | n/a | n/a | -US$59m |
| Dec 31 2022 | US$11m | US$600k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$86m |
| Jun 30 2022 | n/a | n/a | -US$83m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$15m | US$574k | -US$108m |
| Sep 30 2021 | n/a | n/a | -US$82m |
| Jun 30 2021 | n/a | n/a | -US$72m |
| Mar 31 2021 | n/a | n/a | -US$63m |
| Dec 31 2020 | US$27m | US$527k | -US$18m |
| Sep 30 2020 | n/a | n/a | -US$25m |
| Jun 30 2020 | n/a | n/a | -US$38m |
| Mar 31 2020 | n/a | n/a | -US$58m |
| Dec 31 2019 | US$254k | US$254k | -US$72m |
Compensación vs. Mercado: La compensación total de Andrew($USD10.82M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.59M).
Compensación vs. Ingresos: La compensación de Andrew ha aumentado mientras la empresa no es rentable.
CEO
Andrew Dudum (34 yo)
7.3yrs
Permanencia
US$14,401,411
Compensación
Mr. Andrew Dudum serves as Chairman of the Board and serves as Chief Executive Officer at Hims & Hers Health, Inc. since January 20, 2021. He Co-Founded Hims & Hers Health, Inc. in 2017. He is Co-founded H...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 7.3yrs | US$14.40m | 9.21% $ 241.9m | |
| Chief Financial Officer | 2.3yrs | US$7.43m | 0.079% $ 2.1m | |
| Chief Operating Officer | 3.3yrs | US$6.77m | 0.25% $ 6.6m | |
| Chief Legal Officer & Corporate Secretary | 3.3yrs | US$5.21m | 0.077% $ 2.0m | |
| Chief Medical Officer | 1.4yrs | US$198.26k | 0.086% $ 2.3m | |
| Chief Commercial Officer | less than a year | US$6.71m | 0.082% $ 2.2m | |
| Senior VP | 4.9yrs | US$961.12k | 0% $ 0 | |
| Chief Communications Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Human Resources | 2.2yrs | sin datos | sin datos | |
| Senior VP & Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Chief Pharmacy & Innovation Officer | 1.4yrs | sin datos | sin datos | |
| Senior Vice President of Mental Health | 1.2yrs | sin datos | sin datos |
2.2yrs
Permanencia media
43yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de HIMS se considera experimentado (2.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 3.3yrs | US$14.40m | 9.21% $ 241.9m | |
| Chief Medical Officer | 2.3yrs | US$198.26k | 0.086% $ 2.3m | |
| Senior VP & Member of Medical Advisory Board | 2.3yrs | sin datos | sin datos | |
| Independent Director | 3.7yrs | US$194.26k | 0.016% $ 424.6k | |
| Independent Director | 3.5yrs | US$206.76k | sin datos | |
| Independent Director | 3.3yrs | US$203.63k | 0.060% $ 1.6m | |
| Independent Director | less than a year | US$209.76k | 0.033% $ 872.5k | |
| Lead Independent Director | 3.7yrs | US$227.41k | 0.073% $ 1.9m | |
| Independent Director | 3.2yrs | US$205.51k | 0.025% $ 648.9k | |
| Member of Medical Advisory Board | 2.4yrs | sin datos | sin datos | |
| Member of Medical Advisory Board | no data | sin datos | sin datos | |
| Member of Medical Advisory Board | 2.4yrs | sin datos | sin datos |
3.2yrs
Permanencia media
50yo
Promedio de edad
Junta con experiencia: La junta directiva de HIMS se considera experimentada (3.1 años de antigüedad promedio).